Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Minerva Neurosciences, Inc. – NERVGlobeNewsWire • 01/08/21
ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Minerva Neurosciences, Inc. Investors of Important Deadline in Securities Class Action - NERVPRNewsWire • 01/07/21
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 01/06/21
CLASS ACTION UPDATE for BABA, NERV and QIWI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersAccesswire • 01/03/21
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important Deadline in Securities Class Action; Investors with Losses in Excess of $100K Are Encouraged to Contact the Firm – NERVBusiness Wire • 01/02/21
CLASS ACTION UPDATE for NERV, QIWI and TRIT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersAccesswire • 12/31/20
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LRN, YY and NERVAccesswire • 12/29/20
Notice of Lead Plaintiff Deadline for Shareholders in the Minerva Neurosciences, Inc. Class Action LawsuitBusiness Wire • 12/22/20
NERV Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021Business Wire • 12/17/20
SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.– NERVGlobeNewsWire • 12/15/20
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/11/20
NERV STOCK DEADLINE: Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Minerva Neurosciences, Inc. – NERVGlobeNewsWire • 12/11/20
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc. GlobeNewsWire • 12/10/20
NERV INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc.GlobeNewsWire • 12/10/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 12/10/20
NERV INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Minerva Neurosciences, Inc.PRNewsWire • 12/10/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 12/09/20
Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Minerva Neurosciences, Inc. – NERVBusiness Wire • 12/09/20
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 12/09/20
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Minerva Neurosciences, Inc. (NERV)GlobeNewsWire • 12/09/20
MINERVA NEUROSCIENCES ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Minerva Neurosciences, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 12/09/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 12/08/20
Minerva Neurosciences Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of RoluperidoneGlobeNewsWire • 12/01/20
Minerva Neurosciences to Present at Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/09/20
